These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2053 related items for PubMed ID: 8784367

  • 21. Matched unrelated bone marrow transplantation for combined immunodeficiency.
    Dalal I, Reid B, Doyle J, Freedman M, Calderwood S, Saunders F, Roifman CM.
    Bone Marrow Transplant; 2000 Mar; 25(6):613-21. PubMed ID: 10734295
    [Abstract] [Full Text] [Related]

  • 22. Current status of unrelated-donor bone marrow transplantation. The International Marrow Unrelated Search and Transplant (IMUST) Study.
    Bradley BA, Hows JM, Gore SM, Bidwell JL, Clay T, Downie TR, Gluckman E, Howard MR, Laundy GJ.
    Clin Transpl; 1992 Mar; ():91-107. PubMed ID: 1306726
    [Abstract] [Full Text] [Related]

  • 23. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F, Lang PJ, Ottinger H, Faul C, Bethge W, Handgretinger R, Bamberg M, Belka C.
    Int J Radiat Oncol Biol Phys; 2008 Feb 01; 70(2):523-8. PubMed ID: 17869449
    [Abstract] [Full Text] [Related]

  • 24. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
    Buckley RH, Schiff SE, Schiff RI, Markert L, Williams LW, Roberts JL, Myers LA, Ward FE.
    N Engl J Med; 1999 Feb 18; 340(7):508-16. PubMed ID: 10021471
    [Abstract] [Full Text] [Related]

  • 25. Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources.
    Souillet G, Guffon N, Maire I, Pujol M, Taylor P, Sevin F, Bleyzac N, Mulier C, Durin A, Kebaili K, Galambrun C, Bertrand Y, Froissart R, Dorche C, Gebuhrer L, Garin C, Berard J, Guibaud P.
    Bone Marrow Transplant; 2003 Jun 18; 31(12):1105-17. PubMed ID: 12796790
    [Abstract] [Full Text] [Related]

  • 26. Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT).
    Kedar E, Or R, Naparstek E, Zeira E, Slavin S.
    Bone Marrow Transplant; 1988 Mar 18; 3(2):129-40. PubMed ID: 3048477
    [Abstract] [Full Text] [Related]

  • 27. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors.
    Ash RC, Casper JT, Chitambar CR, Hansen R, Bunin N, Truitt RL, Lawton C, Murray K, Hunter J, Baxter-Lowe LA.
    N Engl J Med; 1990 Feb 22; 322(8):485-94. PubMed ID: 2300120
    [Abstract] [Full Text] [Related]

  • 28. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S.
    Blood Cells Mol Dis; 2008 Feb 22; 40(1):48-54. PubMed ID: 17827036
    [Abstract] [Full Text] [Related]

  • 29. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens.
    Kalaycio M, Rybicki L, Pohlman B, Sobecks R, Ball E, Cook D, Andresen S, Kuczkowski E, Bolwell B.
    Bone Marrow Transplant; 2005 Feb 22; 35(3):247-52. PubMed ID: 15580282
    [Abstract] [Full Text] [Related]

  • 30. Bone marrow transplantation in thalassemia major patients using "short" anti-thymocyte globulin therapy in Shiraz, Southern Iran.
    Zakerinia M, Khojasteh HN, Ramzi M, Haghshenas M.
    Transplant Proc; 2005 Dec 22; 37(10):4477-81. PubMed ID: 16387149
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y, Luo B, Sozen H, Kalscheuer H, Blazar BR, Sutherland DE, Hering BJ, Guo Z.
    Transplantation; 2003 Jul 15; 76(1):216-24. PubMed ID: 12865813
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program.
    Kimura F, Sato K, Kobayashi S, Ikeda T, Sao H, Okamoto S, Miyamura K, Mori S, Akiyama H, Hirokawa M, Ohto H, Ashida H, Motoyoshi K, Japan Marrow Donor Program.
    Haematologica; 2008 Nov 15; 93(11):1686-93. PubMed ID: 18835834
    [Abstract] [Full Text] [Related]

  • 38. Prevention of graft-versus-host disease with anti-CD5 ricin A chain immunotoxin after CD3-depleted HLA-nonidentical marrow transplantation in pediatric leukemia patients.
    Przepiorka D, Chan KW, Champlin RE, Culbert SJ, Petropoulos D, Ippoliti C, Khouri I, Huh YO, Vreisendorp H, Deisseroth AB.
    Bone Marrow Transplant; 1995 Dec 15; 16(6):737-41. PubMed ID: 8750262
    [Abstract] [Full Text] [Related]

  • 39. Unrelated donor marrow transplantation for inborn errors.
    Miano M, Porta F, Locatelli F, Miniero R, La Nasa G, Di Bartolomeo P, Giardini C, Messina C, Balduzzi A, Testi AM, Garbarino L, Lanino E, Crescenzi F, Zecca M, Dini G.
    Bone Marrow Transplant; 1998 Apr 15; 21 Suppl 2():S37-41. PubMed ID: 9630323
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 103.